Reunion Neuroscience, MPM BioImpact announce completion of plan of arrangement

Reunion Neuroscience and MPM BioImpact announce the completion of the previously announced plan of arrangement effective today, whereby MPM acquired Reunion in an all-cash transaction valued at approximately US$13.1 million by way of a court-approved plan of arrangement under Section 192 of the Canada Business Corporations Act. Pursuant to the terms and conditions of a definitive arrangement agreement entered into by Reunion and affiliates of MPM on May 31, 2023, all holders of outstanding common shares of Reunion are entitled to receive US$1.12 in cash for each Share held immediately prior to the effective time of the Arrangement.